Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta-analysis.
Body weight
Epidemiologic methods
Health policy
Obesity paradigm
Outcome
Risk factor
Weight change
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
12
10
2018
accepted:
14
11
2018
pubmed:
19
1
2019
medline:
30
4
2020
entrez:
19
1
2019
Statut:
ppublish
Résumé
Guideline recommendations and health policy decisions rely on evidence from clinical and epidemiological studies. Adequate methodology and appropriate conclusions are essential to support healthcare and health policy decisions. An analysis of body mass index and mortality by the Global BMI Mortality Collaboration (GBMC) concluded that the association of excess body weight with higher mortality was similar worldwide and that overweight and obesity should be combated everywhere. To reach this conclusion, the GBMC used highly selected data, rather than a systematic approach. The GBMC initially chose individual participant data from 239 prospective studies with approximately 10.6 million participants. The GBMC then excluded over 60% of data and over 75% of fatal events by eliminating all cases with any reported disease at baseline or smoking history and all events within the first 5 years of follow-up. After applying these restrictions, the association of overweight with lower mortality was reversed and the association of obesity with higher mortality was increased. Given the major flaws in the selection process, in the adequacy of the data, in the data analysis, and in the interpretation, the GBMC conclusions should be viewed sceptically as a guide to action, either for clinical decisions or for public health in general. The flawed conclusion that overweight is uniformly associated with substantially increased risk of death and thus should be combated in any circumstances may lead not only to unjustified treatment efforts and potential harm in a wide range of clinical conditions but also to a tremendous waste of resources.
Identifiants
pubmed: 30656860
doi: 10.1002/jcsm.12378
pmc: PMC6438342
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-13Commentaires et corrections
Type : CommentOn
Informations de copyright
© 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
Int J Obes Relat Metab Disord. 2004 Aug;28(8):1091-6
pubmed: 15197410
J Am Med Dir Assoc. 2015 Nov 1;16(11):933-9
pubmed: 26363864
Scand J Public Health. 2018 Jul;46(5):565-579
pubmed: 29528773
Obes Rev. 2007 Jul;8(4):307-26
pubmed: 17578381
Eur Heart J. 2015 Oct 21;36(40):2729-32
pubmed: 26341892
Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38
pubmed: 24222017
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Int J Epidemiol. 2012 Apr;41(2):472-81
pubmed: 22296991
Int J Epidemiol. 2004 Aug;33(4):751-8
pubmed: 15105409
Int J Epidemiol. 2015 Oct;44(5):1696-705
pubmed: 26208807
JAMA. 2013 Jan 2;309(1):71-82
pubmed: 23280227
N Engl J Med. 1998 Jan 1;338(1):1-7
pubmed: 9414324
Eur J Clin Invest. 2017 Jun;47(6):415-421
pubmed: 28380255
PLoS One. 2014 Oct 08;9(10):e109153
pubmed: 25295620
N Engl J Med. 2006 Aug 24;355(8):779-87
pubmed: 16926276
JAMA. 2013 Apr 24;309(16):1681
pubmed: 23613066
Am J Epidemiol. 2001 Nov 15;154(10):963-71
pubmed: 11700252
Lancet. 2017 Jun 10;389(10086):2284-2285
pubmed: 28612744
J Clin Epidemiol. 2017 Aug;88:30-32
pubmed: 28411079
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083
pubmed: 29098794
Eur Heart J. 2010 Jan;31(2):146-8
pubmed: 19734553
Heart Fail Rev. 2014 Sep;19(5):637-44
pubmed: 24554113
J Clin Epidemiol. 2017 Aug;88:33-36
pubmed: 28411080
Eur J Clin Invest. 2018 Dec;48(12):e12982
pubmed: 29923186
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):9-13
pubmed: 30656860
Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S26-S32
pubmed: 30343719
N Engl J Med. 2008 Nov 13;359(20):2105-20
pubmed: 19005195
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
J Clin Epidemiol. 2017 Aug;88:21-29
pubmed: 28435099
Obes Rev. 2007 Jul;8(4):373-4
pubmed: 17578386
JAMA. 1987 Jan 16;257(3):353-8
pubmed: 3795418
J Gen Intern Med. 2014 Jan;29(1):25-33
pubmed: 23929218
N Engl J Med. 2010 Dec 2;363(23):2211-9
pubmed: 21121834
Am J Epidemiol. 2018 Jan 1;187(1):125-134
pubmed: 29309516
Asia Pac J Clin Nutr. 2006;15(2):127-33
pubmed: 16672195
PLoS One. 2014 Feb 12;9(2):e88641
pubmed: 24533128
Lancet. 2011 Mar 26;377(9771):1085-95
pubmed: 21397319
BMC Med. 2013 Apr 02;11:87
pubmed: 23547896
Lancet. 2009 Mar 28;373(9669):1083-96
pubmed: 19299006
Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):168-181
pubmed: 29981348
Obesity (Silver Spring). 2018 Apr;26(4):629-630
pubmed: 29570246